Author: BusinessWire

Cagent Vascular Raises $30 Million Series C Financing

February 22, 2024

Funds will be used to accelerate US market adoption and to expand the product portfolio of the first and only Serration Angioplasty Technology Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, today announced a Series C Financing close in excess of $30M. U.S. Venture Partners (USVP), led the round. Participation included new […]

Read More

SAIL Fusion Announces First Implantations Of Its BowTie™ Sacroiliac Fusion System

October 18, 2023

SAIL Fusion, a medical device company focused on advancing the surgical treatment of sacroiliac joint dysfunction through solutions built upon AO principles, today announced that it has conducted the first implantations of its novel BowTie SI Fusion System. The surgeries began on October 14th and were conducted by Dr. Peter Whang, Associate Professor of Orthopaedics […]

Read More

Cagent Vascular Announces Initial RECOIL Study Results: Serranator Demonstrates 49% Less Recoil Than POBA In BTK Arteries

July 19, 2023

Cagent Vascular, the exclusive developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its Below-the-Knee (BTK) RECOIL study. This Core Lab-Adjudicated Recoil analysis, the first of its kind, evaluated vessel recoil in lesions treated with Serranator® verses Plain Old Balloon Angioplasty (POBA). The study results demonstrated that lesions treated using […]

Read More

CampusESP Welcomes Customer 300: University Of Kentucky

April 19, 2023

CampusESP, the leading provider of technology solutions that help colleges and universities engage parents and families, announced today that it signed its 300th customer, the University of Kentucky.   Founded in 2016, CampusESP has built a reputation as the go-to leader in parent and family engagement solutions, leading with the message that a strong family […]

Read More

WizeHive Combines Forces with Bright Funds to Create Comprehensive Corporate Giving Solution

November 18, 2021

WizeHive, a leading provider of Grants Management software, today announced a merger with Bright Funds, a leading provider of workplace giving and volunteerism solutions. By bringing together two best-of-breed software providers that power corporate philanthropic missions, WizeHive and Bright Funds will deliver a single SaaS solution that meets the full range of corporate giving needs […]

Read More

University of Kentucky, Children’s Hospital of Philadelphia and Mitochon Pharmaceuticals Awarded NIH Grant for Traumatic Brain Injury Studies

June 23, 2020

Mitochon Pharmaceuticals today announced that they, in partnership with the University of Kentucky (UK) and Children’s Hospital of Philadelphia (CHOP), were awarded a $3.2M National Institutes of Health grant to study Mitochon’s mitochondrial targeted drug therapies for treating Traumatic Brain Injury (TBI). This important award, along with the Company’s open IND, will help pave the […]

Read More

Cagent Vascular Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication and Completion of its PRELUDE-BTK Clinical Trial Enrollment

April 23, 2020

WAYNE, Pa.–(BUSINESS WIRE)– Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating below-the-knee (BTK) lesions. The Serranator device is the first and only angioplasty balloon FDA Cleared and CE Marked that embeds serration technology into a semi-compliant […]

Read More

Acquisition Expands ABBYY’s Digital IQ Capabilities by Combining Content and Process IQ

May 20, 2019

ABBYY, a global leader in Content IQ technologies and solutions, today announced it has signed an agreement to acquire Philadelphia, Pennsylvania-based TimelinePI. TimelinePI provides a comprehensive process intelligence platform designed to empower users to understand, monitor and optimize any business process. The global process analytics market size is expected to grow to USD 1,421.7 million by […]

Read More

SFA Therapeutics Wins Second Key U.S. Patent For Treatment of Chronic Liver Diseases

March 19, 2019

SFA Therapeutics today announced approval of the second key U.S. patent derived from its research & development program, which utilizes microbiome-derived metabolite small molecules as drugs to modulate the body’s anti-inflammatory and immune systems. As a result of this new patent, targeting Ffar2 (GPR43) and Ffar3 (GPR441) and down-regulation of NF-ĸB, the therapeutic applications of […]

Read More

Teleflex Acquires Essential Medical

October 23, 2018

Teleflex Incorporated (NYSE: TFX) today announced that it has acquired Essential Medical, Inc. Based in Exton, PA, Essential Medical is a privately-held medical device company that has developed and commercialized the CE Marked MANTA™ Vascular Closure Device specifically designed for closure of large bore arteriotomies following procedures utilizing devices or sheaths ranging in size from […]

Read More